Casper G Schalkwijk Selected Research

Lipids

1/2023	Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study.
4/2022	Effects of Diet-Induced Weight Loss on Plasma Markers for Cholesterol Absorption and Synthesis: Secondary Analysis of a Randomized Trial in Abdominally Obese Men.
1/2022	A randomized diet-induced weight-loss intervention reduces plasma complement C3: Possible implication for endothelial dysfunction.
1/2022	A 4-week high-AGE diet does not impair glucose metabolism and vascular function in obese individuals.
1/2020	Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study.
1/2018	Reducing sitting time versus adding exercise: differential effects on biomarkers of endothelial dysfunction and metabolic risk.
7/2017	Independent tissue contributors to obesity-associated insulin resistance.
1/2016	Blood lipids influence DNA methylation in circulating cells.
6/2014	Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease. The CODAM study.
4/2012	Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Casper G Schalkwijk Research Topics

Disease

75	Inflammation (Inflammations) 01/2023 - 03/2002
67	Type 2 Diabetes Mellitus (MODY) 01/2024 - 06/2003
47	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 03/2004
31	Atherosclerosis 02/2023 - 03/2002
31	Insulin Resistance 01/2023 - 03/2002
21	Obesity 01/2024 - 03/2002
17	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2022 - 12/2002
13	Prediabetic State (Prediabetes) 11/2023 - 01/2017
13	Hypertension (High Blood Pressure) 10/2022 - 09/2008
12	Albuminuria 01/2022 - 01/2006
11	Fibrosis (Cirrhosis) 08/2015 - 09/2004
10	Hyperglycemia 11/2020 - 12/2002
9	Neoplasms (Cancer) 02/2024 - 06/2005
9	Non-alcoholic Fatty Liver Disease 01/2023 - 07/2011
9	Weight Loss (Weight Reduction) 04/2022 - 01/2017
8	Overweight 01/2023 - 11/2014
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2006
8	Heart Failure 01/2021 - 12/2007
8	Diabetic Nephropathies (Diabetic Nephropathy) 06/2013 - 05/2002
6	Myocardial Infarction 11/2021 - 05/2006
6	Chronic Kidney Failure (Chronic Renal Failure) 10/2020 - 06/2005
5	Hyperemia 10/2022 - 01/2015
5	Glucose Intolerance 01/2022 - 07/2007
5	Diabetes Complications 01/2019 - 05/2008
5	Diabetic Angiopathies (Diabetic Angiopathy) 04/2012 - 05/2002
4	Hypoxia (Hypoxemia) 05/2024 - 11/2010
4	Rupture 01/2023 - 04/2014
4	Diabetes Mellitus 11/2022 - 01/2008
4	Abdominal Obesity 01/2022 - 04/2011
4	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 01/2020
4	Chronic Renal Insufficiency 10/2020 - 01/2019
3	Neoplasm Metastasis (Metastasis) 02/2024 - 10/2016
3	Fatty Liver 03/2023 - 01/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 03/2016
3	Stroke (Strokes) 01/2021 - 05/2006
3	Fructose Intolerance (Intolerance, Fructose) 06/2020 - 11/2019
3	Renal Insufficiency (Renal Failure) 05/2020 - 03/2004
3	Cerebral Small Vessel Diseases 01/2020 - 01/2020
3	Multiple Sclerosis 01/2019 - 02/2017
3	Atherosclerotic Plaque (Atheroma) 01/2019 - 05/2014
3	Depressive Disorder (Melancholia) 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

71	Advanced Glycation End ProductsIBA 01/2023 - 01/2002
53	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 06/2005
43	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2006
31	Pyruvaldehyde (Methylglyoxal)IBA 05/2024 - 09/2006
28	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2023 - 03/2004
19	C-Reactive ProteinIBA 12/2022 - 02/2003
16	Insulin (Novolin)FDA Link 01/2024 - 03/2002
14	Proteins (Proteins, Gene)FDA Link 11/2022 - 06/2005
14	SelectinsIBA 10/2022 - 03/2004
12	LipidsIBA 01/2023 - 07/2007
12	pentosidineIBA 10/2021 - 03/2009
11	von Willebrand FactorIBA 01/2022 - 03/2004
11	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2016 - 02/2011
10	Glyoxal (Ethanedial)IBA 02/2024 - 01/2014
10	Retinaldehyde (Retinal)IBA 10/2022 - 12/2016
10	CholesterolIBA 04/2022 - 05/2014
10	E-SelectinIBA 01/2022 - 03/2004
9	3-deoxyglucosoneIBA 02/2024 - 03/2011
9	Dietary Advanced Glycation End ProductsIBA 01/2023 - 07/2015
9	Triglycerides (Triacylglycerol)IBA 10/2020 - 05/2014
9	Lysine (L-Lysine)FDA Link 10/2020 - 02/2011
9	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 05/2008
9	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2015 - 06/2005
8	Complement System Proteins (Complement)IBA 01/2023 - 12/2012
8	Interleukin-8 (Interleukin 8)IBA 01/2017 - 10/2011
7	Receptor for Advanced Glycation End ProductsIBA 01/2021 - 04/2008
7	HDL CholesterolIBA 01/2020 - 05/2015
7	EnzymesIBA 01/2019 - 03/2004
6	Interleukin-6 (Interleukin 6)IBA 01/2023 - 02/2011
6	CollagenIBA 11/2022 - 01/2002
6	FructoseIBA 10/2022 - 11/2019
6	Complement C3 (C3 Complement)IBA 01/2022 - 04/2011
6	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 04/2010
5	Syntex adjuvant formulationIBA 11/2023 - 01/2017
5	AlbuminsIBA 12/2016 - 05/2002
5	ThrombomodulinIBA 03/2015 - 03/2004
5	AdipokinesIBA 06/2014 - 11/2010
4	PyridoxamineIBA 02/2023 - 01/2016
4	Complement Factor D (Factor D)IBA 01/2023 - 12/2018
4	Metformin (Glucophage)FDA LinkGeneric 10/2022 - 05/2008
4	Arginine (L-Arginine)FDA Link 10/2022 - 09/2006
4	Matrix Metalloproteinases (MMPs)IBA 07/2020 - 03/2015
4	LDL CholesterolIBA 01/2020 - 07/2007
4	OsteopontinIBA 01/2018 - 01/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016 - 11/2005
4	AdiponectinIBA 02/2013 - 06/2003
4	Plasminogen Activator Inhibitor 1IBA 03/2012 - 06/2005
4	Peptides (Polypeptides)IBA 01/2008 - 01/2005
3	SaltsIBA 10/2022 - 11/2014
3	Cell Adhesion MoleculesIBA 01/2022 - 07/2011
3	C-PeptideIBA 10/2020 - 01/2017
3	InterleukinsIBA 01/2018 - 03/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2008
3	hydroxide ionIBA 01/2017 - 09/2008
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016 - 05/2008

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2011
3	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2020 - 01/2019
3	Renal Dialysis (Hemodialysis) 01/2019 - 10/2013
3	Peritoneal Dialysis 01/2019 - 04/2004